AROC vs NOV
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AROC · Archrock$25.37 ▼ 5.30%
NOV · NOV Inc$16.02 ▼ 2.73%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AROC +10.6%
- NOV +9.0%
Head to head
| Metric | AROC | NOV |
|---|---|---|
| Price | $25.37 | $16.02 |
| Change today | ▼ 5.30% | ▼ 2.73% |
| Market cap | $4.45B | $5.71B |
| Return, 3 months | -17.4% | -18.6% |
| Return, year to date | -0.6% | +4.3% |
| Return, 1 year | +10.9% | +9.6% |
| P/E (TTM) | 13.1 | 39.1 |
| P/B | 2.8 | 0.9 |
| P/E percentile vs own 5y | 0th | 75th |
| Dividend yield | 3.47% | 2.72% |
| Revenue growth (YoY, latest qtr) | -3.0% | +2.3% |
| Net profit growth (YoY) | +18.6% | +115.9% |
| Gross margin | 48.6% | 20.7% |
| Operating margin | 38.8% | 6.3% |
| Net margin | 22.7% | 1.6% |
| Return on equity | 22.4% | 2.3% |
| Analyst target vs. price | +64.6% | +42.8% |
| Analyst buy share | 100% | 50% |
| RSI (14) | 34 | 27 |
| 30-day volatility | 56.1% | 37.1% |
| Max drawdown, 1 year | -39.1% | -25.9% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NOV is the largest of the group by market value.
- AROC has returned the most over the past year.
- AROC carries the lowest trailing P/E.
- AROC pays the highest dividend yield.
- NOV is growing revenue fastest.
- AROC keeps the most profit per dollar of sales.
- NOV has been the calmest stock over the last 30 days.